Survival of Chinese Patients With Pulmonary Arterial Hypertension in the Modern Treatment Era
Author:
Publisher
Elsevier BV
Reference28 articles.
1. Primary pulmonary hypertension;Rubin;N Engl J Med,1997
2. Pulmonary arterial hypertension;Farber;N Engl J Med,2004
3. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival;Sitbon;J Am Coll Cardiol,2002
4. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy;McLaughlin;Circulation,2002
5. Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension;Provencher;Eur Heart J,2006
Cited by 183 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impaired right atrial function preceding right ventricular systolic dysfunction: clinical utility and long-term prognostic value in pulmonary hypertension;Insights into Imaging;2025-06-04
2. Burden of pulmonary arterial hypertension in Asia from 1990 to 2021: Findings from Global Burden of Disease Study 2021;Chinese Medical Journal;2025-05-16
3. Statistical modeling to determine severity of respiratory sarcoidosis and parameters associated with cardiac sarcoidosis: as a way to stratify the risk of developing pulmonary hypertension;Bulletin of Siberian Medicine;2025-04-14
4. Plasma IL4 Levels Linked to Pulmonary Hypertension Severity and Outcome;Clinical and Experimental Pharmacology and Physiology;2025-04-10
5. Prevalence, molecular mechanisms and diagnostic approaches to pulmonary arterial hypertension in connective tissue diseases;Rheumatology International;2025-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3